Home » Newsletters » BioWorld Science

BioWorld Science

June 18, 2020

View Archived Issues

How CDK comes unglued

HRAS-driven translation helps skin prevent tumors

Phase I study of BAY-1436032 in advanced AML patients with mutant IDH1

Preliminary phase I results suggest neihulizumab safety and efficacy in sr-aGvHD

Hyundai Pharmaceutical presents phase I data for GPR40 agonist HD-6277 in type 2 diabetes

Stayble Therapeutics initiates phase IIb study of STA-363

Positive data presented from FASCINATE-1 phase II study of ASC-40

Dare Bioscience initiates pivotal phase III study of DARE-BV1 in bacterial vaginosis

Encouraging interim data presented from phase II/III study of IFX-1 in severe COVID-19

Safety run-in results from phase I/II study of VXM-01 plus avelumab in progressive glioblastoma

First clinical results presented for PXS-5505

Otsuka Pharmaceutical presents new antiseizure compounds

New MALT1 inhibitors discovered at Takeda

Novartis describes new PCSK9 inhibitors

Merck & Co. patents IDO-1 inhibitors

GlaxoSmithKline and collaborators identify NF-kappaB activators/HIV latency-reversing agents

Xoc Pharmaceuticals presents phase I data for XC101-D13H in preventing migraine

Aevi begins phase II study of CERC-002 in patients with COVID-19 pneumonia and acute lung injury

Preclinical and phase I studies demonstrate KER-050 potential for treating hematopoiesis disorders

Sanofi begins phase III trials of SAR-442168 in MS

ViralClear enrolls patients with advanced COVID-19 in phase II trial of merimepodib with remdesivir

New phase I trial studies TQB-3474 in advanced malignant tumors

New targets and "molecular beacon" give new insights into senescence

Phase II trial explores axatilimab in patients with respiratory involvement secondary to COVID-19

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...